Impact Biomedical Inc. (IBO) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
IMPACT BIOMEDICAL INC.  (NYSE: IBO)


Impact Biomedical's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Impact Biomedical's ROI in the second quarter of 2026?
IMPACT BIOMEDICAL INC. achieved a return on average invested assets (ROI) of 5.68 % in its second quarter of 2026 a new company high.

ROI has improved compared to -144.85% in the first quarter of 2026, due to net income growth.

Within the Healthcare sector 109 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 4066 to 4162.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -35.37 % -69.11 % -78.2 % -76.82 % -36.18 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 18 20 23 -6 -1
Return On Investment (TTM) 5.68 % -144.85 % -164.56 % - -
IBO's Overall Ranking # 4162 # 4066 # # #
Seq. Investment Change TTM 53.71 % 23.24 % -14.28 % -60.2 % -26.53 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 1 -13 -12 -44 -39

IBO Company Profile >> Back to IBO Roi Comparisons >> See Annual IBO Return On Investment



Return On Investment IBO's Ranking
Within: No.
Industry # 39
Sector # 110
Overall # 4162

Return On Investment Statistics
High Average Low
5.68 %
-141.43 %
-576.4 %
(Jun 30 2026)   (Sep 30 2025)







Financial Statements
Impact Biomedical's II. Quarter Investments $ 18 Millions IBO's Balance sheet
Impact Biomedical's II. Quarter Income $ -1 Millions Quarterly IBO's Income Statement
IBO's Income by Division See IBO's Income by Division


IBO Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2022)
2023

Total Investments in Millions 23 27 40 0 0
Y / Y Investment Growth -17.57 % -31.96 % - - -
Net Income in Millions -12 -25 -7 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -52.65 % -90.57 % -17.54 % - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IBO's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IBO's Competitors
Subscribers only: Roi for Impact Biomedical's Suppliers
Subscribers only: Return On Investment for IBO's Customers

Other Ratios
IBO's Roa IBO's Inventory Turnover Ratio IBO's Growth Rates IBO's Dividend Statistics
IBO's Profitability Ratios IBO's Asset Turnover Ratio IBO's Dividend Growth
IBO's Roe IBO's Valuation Ratios IBO's Financial Strength Ratios IBO's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Nephros Inc   15.31 %
West Pharmaceutical Services Inc   15.29 %
Progyny Inc   15.25 %
Biolife Solutions Inc   14.83 %
Sbc Medical Group Holdings Incorporated  14.78 %
Spero Therapeutics Inc   14.54 %
Insulet Corporation  14.30 %
Alpha Pro Tech Ltd   13.80 %
Bristol myers Squibb Company  13.58 %
Transmedics Group Inc   13.46 %
Strata Critical Medical Inc   13.34 %
Johnson and Johnson  13.30 %
Amgen Inc   13.08 %
Medinotec Inc   13.06 %
Lantheus Holdings Inc   13.02 %
Msa Safety Inc  13.02 %
Universal Health Services Inc   12.43 %
Ufp Technologies Inc   12.12 %
Solventum Corporation  11.98 %
Ligand Pharmaceuticals Incorporated  11.93 %
Lifevantage Corp  11.84 %
Regeneron Pharmaceuticals Inc   11.83 %
Protagonist Therapeutics inc   11.66 %
Encompass Health Corporation  11.56 %
Embecta Corp   11.20 %
Lemaitre Vascular Inc   11.20 %
3m Company  11.16 %
Globus Medical Inc   11.01 %
National Healthcare Corp  10.91 %
Bioventus Inc   10.85 %

Date modified: 2026-09-26T07:44:20+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.